Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the interests of the connected persons of Persons Discharging Managerial Responsibility, in the Ordinary Shares and American Depositary Shares (ADS) of GlaxoSmithKline plc following the sale of Ordinary Shares and ADS at a price of £14.55 per Ordinary Share and of $44.03 per ADS on 1 March 2013, to meet their tax liabilities following the vesting of awards granted in 2010 under the GlaxoSmithKline Share Value Plan:
Name of PDMR |
Name of Connected Person |
Number of Shares sold |
Number of Shares retained |
Mr P Thomson
|
Mrs K Thomson |
436 (Ordinary Shares) |
401 (Ordinary Shares)
|
Dr M Slaoui*
|
Mrs K Slaoui |
230 (ADS) |
410 (ADS) |
* Denotes an Executive Director
The Company and the above individuals were advised of these transactions on 1 March 2013.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
V A Whyte
Company Secretary
4 March 2013